Sfoglia per Autore
Prevalence and the relative role of the main predictors of metabolic syndrome development in the hystorical cohort of the Brisighella heart study: 16-years follow-up
2004 Cicero A.F.G.; Miconi A.; Dormi A.; D'Addato S.; Laghi L.; Grandi E.; Gaddi A.
Regressione completa di xantelasmi palpebrali in seguito a prolungatra terapia con statine: Case Report
2004 Bernardi, R.; D'Addato, S.; Papachristou, A.; Cicero, A.F.G.; Gaddi, A.
Effect of a dietary education program on plasma lipid level in a rural setting: the Brisighella Heart Study
2004 D'Addato S.; Dormi A.; Fiorito A.; Cicero A.F.G.; Bernardi R.; Gaddi A.;
Introduzione
2004 BUSBY LC; BERTONI JM; DIXON D; ET AL.; Gaddi A. curatore
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Heart Study.
2004 Borghi C; Dormi A; Gaddi A; Immordino V; Veronesi M; Ambrosioni E
Metabolic Effects of Pioglitazone and Rosiglitazone in patients with diabetes and metabolic syndrome treated with Glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.
2004 DEROSA G; CICERO AFG; GADDI A.; RAGONESI PD; FOGARI E; BERTONE G; CICCARELLI L; PICCININI MN.
Effects of Siberian ginseng (Eleutherococcus senticosus maxim.) on elderly quality of life: a randomized clinical trial.
2004 CICERO AF; DEROSA G; BRILLANTE R; BERNARDI R; NASCETTI S; GADDI A.
Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study
2004 Borghi, Claudio; Dormi, Ada; D'Addato, S; Gaddi, Antonio; Ambrosioni, Ettore; on behalf of the Brisighella Heart Study Working Party
Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept.
2004 GADDI A.; CICERO AF; PEDRO EJ.
Assessment of the health status in the Massa Lombarda cohort: a preliminary description of the program evaluating cardio-cerebro-vascular disease risk factors and quality of life in an elderly population.
2004 Nascetti S.; Linarello S., Scurti M., Grandi E., Gaddoni M., Noera G., Gaddi A.
Effects of a new low dose soy protein β-sitosterol association on plasma lipid levels and oxidation
2004 CICERO AFG; MINARDI M; MIREMBE S; PEDRO E; GADDI A.
Possible role of ubiquinone in the treatment of massive hypertriglyceridemia resistant to PUFA and fibrates.
2005 Cicero AF; Derosa G; Miconi A; Laghi L; Nascetti S; Gaddi A.
Primary variation in serum HDL-cholesterol levels: an independent cardiovascular risk factor in healthy adults?
2005 Bove M, Cicero AFG; Lucicesare A, Aronis K, Georgounis I, Gaddi AV
Le dislipidemie nel paziente diabetico.
2005 Cucinotta D; Gaddi AV; Russo GT; Cicero AFG.
Case Report: lipoproteina (A) is an indipendent risk factor for coronary artery disease: diagnosis and follow-up of a patient with high level of Lp(a) as only cardiovascular risk factor
2005 Bernardi R.; D'Addato S.; Dormi A.; Brillante R.; Laghi L.; Linarello S.; Grandi E.; Gaddi A.
Cost-effetiveness analysis of complementary care for hyperlipidameias
2005 Cicero AFG; Bove M; Lucicsare A; Laghi L; Gaddi AV.
Coenzyne Q10 effect on the serum creatinine increase associated to rosuvastatin 20 mg in severe hypercholesterolemic patients
2005 A.F.G., Cicero; G., Derosa; M., Bove; A., Lucicesare; L., Laghi; S., D'Addato; A.Gaddi.
Assocaition between hyperCKPemia and hypercholesterolemia in general population: casual phenotype or genic cluster?
2005 Lucicesare A; Cicero AFG; Bove M; Aronis K; Bernardi R; Gaddi A.
Physical activity and cardiovascular disease mortality: the Brisighella heart study
2005 D'Addato S.; Dormi A.; Bernardi R.; Borghi C.; Gaddi A.
Temporal trend of antihypertensive drugs therapy and blood pressure control in the Brisighella Herat Study.
2005 Borghi C; Dormi A; Gaddi A; Cosentino E; Immordino V; Ambrosioni E
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile